Dr. Gabriel E. Mena, MD

Dr. Mena practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Mena's NPI, 1205920030, was assigned on October 3, 2006. Dr. Mena graduated from Pontifical Xavierian University in 1996. Dr. Mena holds Texas license M1932.

Dr. Mena's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Mena's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mena practices. Vendor and product names are available with a free account.

Anesthesiology is Dr. Mena's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Mena is board certified in anesthesiology by the American Board of Anesthesiology. Dr. Mena is licensed in Texas.

CMS data shows 178 Medicare services from Dr. Mena across 7 procedure codes in 2024, for 243 Medicare patients. Medicare paid $16,473 for them.

CMS counts 243 Medicare patients who saw Dr. Mena in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mena's median patient age at 62, with 57% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Mena for performance year 2024, reported as part of a group. Dr. Mena accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 57 papers to Dr. Mena, published from 2012 to 2025. 2021 was the busiest year, with 10. The most frequent topics are Enhanced Recovery After Surgery, Gynecologic Surgical Procedures and Postoperative Complications. Dr. Mena has published most often in Int J Gynecol Cancer. Dr. Mena's most frequent co-authors are Javier David Lasala, MD, Pedro T. Ramirez, MD and David C. Rice, MD.

Dmand AI links Dr. Mena to 1 clinical trial. Conditions studied include Spinal Diseases and Esophageal Diseases.

CMS Open Payments shows 169 general payments to Dr. Mena from 14 drug and device companies from 2016 to 2025. Ownership or investment make up the largest share, 51% of the total. Pacira Pharmaceuticals Incorporated paid the most, $680,890.

Dr. Mena graduated from Pontifical Xavierian University in 1996.

Dr. Mena is in network with 3 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.